Head-to-head · Cost-Efficiency Index
Kin Meds vs AMP Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Kin Meds
Shoppers modeling the real monthly cost before they commit.
Visit Kin MedsAMP Health
Patients in the MD/VA/DC region wanting an NP-led hormone-and-weight-management practice.
Visit AMP HealthThe verdict
Kin Meds takes it, leading the Cost-Efficiency Index 47 to 46. Kin Meds is a GLP-1 telehealth provider whose own website could not be accessed for live verification due to active bot-protection/CAPTCHA (confirmed via direct fetch, a text-rendering proxy, and live browser automation). AMP Health still earns a C — Patients in the MD/VA/DC region wanting an NP-led hormone-and-weight-management practice.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Kin Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Kin Meds | AMP Health |
|---|---|---|
| Cost-Efficiency Index | 47/100 | 46/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #447 | #451 |
Kin Meds
47/100Where the value is
- Appears to have an established web/social presence per search results
The tradeoffs
- Site is unreachable for independent verification behind active bot/CAPTCHA protection
- No pricing, medical director, or pharmacy partner could be confirmed directly from the company
Regulatory note: the FDA issued a warning letter to Kin Meds in February 2026. We still list and link to Kin Meds; you should know the letter is on the public record before you decide.
AMP Health
46/100Where the value is
- Named founder and clinical lead (Amanda Peyronel, CRNP)
- Transparent, low consultation fee for the weight-management visit ($100)
- Offers injectable GLP-1s alongside broader hormone therapy
The tradeoffs
- No actual semaglutide/tirzepatide drug pricing published anywhere on the site
- Limited to three states (MD, VA, DC) rather than a national telehealth footprint
Regulatory note: the FDA issued a warning letter to Dripgym Mobile Parent, LLC dba Amp Health in February 2026. We still list and link to AMP Health; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.